nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—hypertension—type 2 diabetes mellitus	0.385	1	CtDrD
Labetalol—ADRB3—type 2 diabetes mellitus	0.26	1	CbGaD
Labetalol—Quinapril—Ramipril—type 2 diabetes mellitus	0.0678	0.512	CrCrCtD
Labetalol—Benazepril—Ramipril—type 2 diabetes mellitus	0.0646	0.488	CrCrCtD
Labetalol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0458	0.442	CbGbCtD
Labetalol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.017	0.164	CbGbCtD
Labetalol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0157	0.151	CbGbCtD
Labetalol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0129	0.124	CbGbCtD
Labetalol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0123	0.119	CbGbCtD
Labetalol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00382	0.77	CbGeAlD
Labetalol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000515	0.104	CbGeAlD
Labetalol—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.000398	0.173	CrCbGaD
Labetalol—Mirabegron—ADRB3—type 2 diabetes mellitus	0.000334	0.145	CrCbGaD
Labetalol—Fenoterol—ADRB3—type 2 diabetes mellitus	0.000294	0.128	CrCbGaD
Labetalol—Arbutamine—ADRB3—type 2 diabetes mellitus	0.000275	0.119	CrCbGaD
Labetalol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000239	0.0482	CbGeAlD
Labetalol—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000211	0.0425	CbGeAlD
Labetalol—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000144	0.0623	CrCbGaD
Labetalol—Benazepril—MTHFR—type 2 diabetes mellitus	0.00012	0.052	CrCbGaD
Labetalol—Quinapril—ACE—type 2 diabetes mellitus	0.000112	0.0487	CrCbGaD
Labetalol—CYP2D6—kidney—type 2 diabetes mellitus	0.000109	0.0219	CbGeAlD
Labetalol—Benazepril—ACE—type 2 diabetes mellitus	9.77e-05	0.0424	CrCbGaD
Labetalol—Mirabegron—CYP3A4—type 2 diabetes mellitus	6.96e-05	0.0302	CrCbGaD
Labetalol—CYP2D6—liver—type 2 diabetes mellitus	6.88e-05	0.0139	CbGeAlD
Labetalol—Rash—Glipizide—type 2 diabetes mellitus	6.62e-05	0.000812	CcSEcCtD
Labetalol—Vision blurred—Irbesartan—type 2 diabetes mellitus	6.61e-05	0.000811	CcSEcCtD
Labetalol—Dermatitis—Glipizide—type 2 diabetes mellitus	6.61e-05	0.000811	CcSEcCtD
Labetalol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	6.61e-05	0.00081	CcSEcCtD
Labetalol—Erythema—Losartan—type 2 diabetes mellitus	6.6e-05	0.00081	CcSEcCtD
Labetalol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	6.58e-05	0.000808	CcSEcCtD
Labetalol—Oedema—Orlistat—type 2 diabetes mellitus	6.58e-05	0.000808	CcSEcCtD
Labetalol—Headache—Glipizide—type 2 diabetes mellitus	6.58e-05	0.000806	CcSEcCtD
Labetalol—Tremor—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.000806	CcSEcCtD
Labetalol—Palpitations—Metformin—type 2 diabetes mellitus	6.57e-05	0.000806	CcSEcCtD
Labetalol—Shock—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000804	CcSEcCtD
Labetalol—Loss of consciousness—Metformin—type 2 diabetes mellitus	6.54e-05	0.000801	CcSEcCtD
Labetalol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	6.51e-05	0.000799	CcSEcCtD
Labetalol—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	6.51e-05	0.000798	CcSEcCtD
Labetalol—Hepatitis—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000798	CcSEcCtD
Labetalol—Dizziness—Glimepiride—type 2 diabetes mellitus	6.48e-05	0.000794	CcSEcCtD
Labetalol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	6.47e-05	0.000793	CcSEcCtD
Labetalol—Dizziness—Sitagliptin—type 2 diabetes mellitus	6.46e-05	0.000792	CcSEcCtD
Labetalol—Somnolence—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000791	CcSEcCtD
Labetalol—Hypertension—Metformin—type 2 diabetes mellitus	6.42e-05	0.000787	CcSEcCtD
Labetalol—Urticaria—Glyburide—type 2 diabetes mellitus	6.42e-05	0.000787	CcSEcCtD
Labetalol—Angioedema—Irbesartan—type 2 diabetes mellitus	6.41e-05	0.000786	CcSEcCtD
Labetalol—Oedema peripheral—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000786	CcSEcCtD
Labetalol—Abdominal pain—Glyburide—type 2 diabetes mellitus	6.39e-05	0.000783	CcSEcCtD
Labetalol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6.38e-05	0.000783	CcSEcCtD
Labetalol—Salmeterol—CYP3A4—type 2 diabetes mellitus	6.37e-05	0.0276	CrCbGaD
Labetalol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	6.37e-05	0.000781	CcSEcCtD
Labetalol—Muscle spasms—Losartan—type 2 diabetes mellitus	6.35e-05	0.000779	CcSEcCtD
Labetalol—Asthenia—Bromocriptine—type 2 diabetes mellitus	6.34e-05	0.000777	CcSEcCtD
Labetalol—Malaise—Irbesartan—type 2 diabetes mellitus	6.33e-05	0.000776	CcSEcCtD
Labetalol—Vertigo—Irbesartan—type 2 diabetes mellitus	6.3e-05	0.000773	CcSEcCtD
Labetalol—Headache—Pioglitazone—type 2 diabetes mellitus	6.3e-05	0.000772	CcSEcCtD
Labetalol—Syncope—Irbesartan—type 2 diabetes mellitus	6.29e-05	0.000772	CcSEcCtD
Labetalol—Visual impairment—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000769	CcSEcCtD
Labetalol—Discomfort—Metformin—type 2 diabetes mellitus	6.25e-05	0.000767	CcSEcCtD
Labetalol—Fatigue—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000767	CcSEcCtD
Labetalol—Nausea—Glipizide—type 2 diabetes mellitus	6.23e-05	0.000765	CcSEcCtD
Labetalol—Vomiting—Glimepiride—type 2 diabetes mellitus	6.23e-05	0.000764	CcSEcCtD
Labetalol—Hypotension—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000764	CcSEcCtD
Labetalol—Vision blurred—Losartan—type 2 diabetes mellitus	6.22e-05	0.000763	CcSEcCtD
Labetalol—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.21e-05	0.000761	CcSEcCtD
Labetalol—Pain—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.000761	CcSEcCtD
Labetalol—Constipation—Gliclazide—type 2 diabetes mellitus	6.2e-05	0.000761	CcSEcCtD
Labetalol—Tremor—Losartan—type 2 diabetes mellitus	6.19e-05	0.000759	CcSEcCtD
Labetalol—Rash—Glimepiride—type 2 diabetes mellitus	6.18e-05	0.000757	CcSEcCtD
Labetalol—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.17e-05	0.000757	CcSEcCtD
Labetalol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000756	CcSEcCtD
Labetalol—Rash—Sitagliptin—type 2 diabetes mellitus	6.16e-05	0.000755	CcSEcCtD
Labetalol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.15e-05	0.000754	CcSEcCtD
Labetalol—Headache—Glimepiride—type 2 diabetes mellitus	6.14e-05	0.000752	CcSEcCtD
Labetalol—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.13e-05	0.000751	CcSEcCtD
Labetalol—Headache—Sitagliptin—type 2 diabetes mellitus	6.12e-05	0.00075	CcSEcCtD
Labetalol—Mirabegron—ALB—type 2 diabetes mellitus	6.07e-05	0.0263	CrCbGaD
Labetalol—Oedema—Metformin—type 2 diabetes mellitus	6.07e-05	0.000744	CcSEcCtD
Labetalol—Hypertension—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000743	CcSEcCtD
Labetalol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.05e-05	0.000741	CcSEcCtD
Labetalol—Flushing—Ramipril—type 2 diabetes mellitus	6.04e-05	0.00074	CcSEcCtD
Labetalol—Angioedema—Losartan—type 2 diabetes mellitus	6.03e-05	0.00074	CcSEcCtD
Labetalol—Paraesthesia—Valsartan—type 2 diabetes mellitus	5.98e-05	0.000734	CcSEcCtD
Labetalol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	5.98e-05	0.000733	CcSEcCtD
Labetalol—Shock—Metformin—type 2 diabetes mellitus	5.97e-05	0.000732	CcSEcCtD
Labetalol—Malaise—Losartan—type 2 diabetes mellitus	5.96e-05	0.00073	CcSEcCtD
Labetalol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	5.95e-05	0.00073	CcSEcCtD
Labetalol—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.94e-05	0.000729	CcSEcCtD
Labetalol—Vertigo—Losartan—type 2 diabetes mellitus	5.93e-05	0.000728	CcSEcCtD
Labetalol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.93e-05	0.000727	CcSEcCtD
Labetalol—Somnolence—Valsartan—type 2 diabetes mellitus	5.92e-05	0.000727	CcSEcCtD
Labetalol—Syncope—Losartan—type 2 diabetes mellitus	5.92e-05	0.000726	CcSEcCtD
Labetalol—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.91e-05	0.000725	CcSEcCtD
Labetalol—Discomfort—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000724	CcSEcCtD
Labetalol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.87e-05	0.000719	CcSEcCtD
Labetalol—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.87e-05	0.000719	CcSEcCtD
Labetalol—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.84e-05	0.000717	CcSEcCtD
Labetalol—Palpitations—Losartan—type 2 diabetes mellitus	5.84e-05	0.000716	CcSEcCtD
Labetalol—Nausea—Glimepiride—type 2 diabetes mellitus	5.82e-05	0.000713	CcSEcCtD
Labetalol—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.8e-05	0.000712	CcSEcCtD
Labetalol—Nausea—Sitagliptin—type 2 diabetes mellitus	5.8e-05	0.000711	CcSEcCtD
Labetalol—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.8e-05	0.000711	CcSEcCtD
Labetalol—Asthenia—Glyburide—type 2 diabetes mellitus	5.8e-05	0.000711	CcSEcCtD
Labetalol—Urticaria—Gliclazide—type 2 diabetes mellitus	5.76e-05	0.000707	CcSEcCtD
Labetalol—Alopecia—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000705	CcSEcCtD
Labetalol—Fatigue—Valsartan—type 2 diabetes mellitus	5.75e-05	0.000705	CcSEcCtD
Labetalol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.000703	CcSEcCtD
Labetalol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.000703	CcSEcCtD
Labetalol—Oedema—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000702	CcSEcCtD
Labetalol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000702	CcSEcCtD
Labetalol—Pruritus—Glyburide—type 2 diabetes mellitus	5.71e-05	0.000701	CcSEcCtD
Labetalol—Mental disorder—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000699	CcSEcCtD
Labetalol—Constipation—Valsartan—type 2 diabetes mellitus	5.7e-05	0.000699	CcSEcCtD
Labetalol—Fatigue—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000696	CcSEcCtD
Labetalol—Hypotension—Metformin—type 2 diabetes mellitus	5.67e-05	0.000695	CcSEcCtD
Labetalol—Erythema—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000694	CcSEcCtD
Labetalol—Shock—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000691	CcSEcCtD
Labetalol—Pain—Orlistat—type 2 diabetes mellitus	5.63e-05	0.000691	CcSEcCtD
Labetalol—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.62e-05	0.000689	CcSEcCtD
Labetalol—Rash—Bromocriptine—type 2 diabetes mellitus	5.57e-05	0.000683	CcSEcCtD
Labetalol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.57e-05	0.000683	CcSEcCtD
Labetalol—Discomfort—Losartan—type 2 diabetes mellitus	5.55e-05	0.000681	CcSEcCtD
Labetalol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.000679	CcSEcCtD
Labetalol—Headache—Bromocriptine—type 2 diabetes mellitus	5.54e-05	0.000679	CcSEcCtD
Labetalol—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.53e-05	0.000678	CcSEcCtD
Labetalol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.45e-05	0.000668	CcSEcCtD
Labetalol—Paraesthesia—Metformin—type 2 diabetes mellitus	5.45e-05	0.000668	CcSEcCtD
Labetalol—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000668	CcSEcCtD
Labetalol—Confusional state—Losartan—type 2 diabetes mellitus	5.43e-05	0.000666	CcSEcCtD
Labetalol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.43e-05	0.000665	CcSEcCtD
Labetalol—Dyspnoea—Metformin—type 2 diabetes mellitus	5.41e-05	0.000663	CcSEcCtD
Labetalol—Somnolence—Metformin—type 2 diabetes mellitus	5.39e-05	0.000662	CcSEcCtD
Labetalol—Oedema—Losartan—type 2 diabetes mellitus	5.39e-05	0.000661	CcSEcCtD
Labetalol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.39e-05	0.000661	CcSEcCtD
Labetalol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.38e-05	0.00066	CcSEcCtD
Labetalol—Hypotension—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000656	CcSEcCtD
Labetalol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.34e-05	0.000655	CcSEcCtD
Labetalol—Dyspepsia—Metformin—type 2 diabetes mellitus	5.34e-05	0.000655	CcSEcCtD
Labetalol—Tremor—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000651	CcSEcCtD
Labetalol—Shock—Losartan—type 2 diabetes mellitus	5.3e-05	0.00065	CcSEcCtD
Labetalol—Urticaria—Valsartan—type 2 diabetes mellitus	5.29e-05	0.000649	CcSEcCtD
Labetalol—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.27e-05	0.000646	CcSEcCtD
Labetalol—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.25e-05	0.000644	CcSEcCtD
Labetalol—Nausea—Bromocriptine—type 2 diabetes mellitus	5.25e-05	0.000644	CcSEcCtD
Labetalol—Fatigue—Metformin—type 2 diabetes mellitus	5.23e-05	0.000642	CcSEcCtD
Labetalol—Urticaria—Orlistat—type 2 diabetes mellitus	5.23e-05	0.000642	CcSEcCtD
Labetalol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.21e-05	0.000639	CcSEcCtD
Labetalol—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000638	CcSEcCtD
Labetalol—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.21e-05	0.000638	CcSEcCtD
Labetalol—Asthenia—Gliclazide—type 2 diabetes mellitus	5.2e-05	0.000638	CcSEcCtD
Labetalol—Constipation—Metformin—type 2 diabetes mellitus	5.19e-05	0.000636	CcSEcCtD
Labetalol—Angioedema—Ramipril—type 2 diabetes mellitus	5.17e-05	0.000634	CcSEcCtD
Labetalol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.14e-05	0.000631	CcSEcCtD
Labetalol—Vomiting—Glyburide—type 2 diabetes mellitus	5.14e-05	0.00063	CcSEcCtD
Labetalol—Pruritus—Gliclazide—type 2 diabetes mellitus	5.13e-05	0.000629	CcSEcCtD
Labetalol—Malaise—Ramipril—type 2 diabetes mellitus	5.11e-05	0.000626	CcSEcCtD
Labetalol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000626	CcSEcCtD
Labetalol—Rash—Glyburide—type 2 diabetes mellitus	5.09e-05	0.000625	CcSEcCtD
Labetalol—Somnolence—Irbesartan—type 2 diabetes mellitus	5.09e-05	0.000624	CcSEcCtD
Labetalol—Dermatitis—Glyburide—type 2 diabetes mellitus	5.09e-05	0.000624	CcSEcCtD
Labetalol—Vertigo—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000624	CcSEcCtD
Labetalol—Syncope—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000623	CcSEcCtD
Labetalol—Headache—Glyburide—type 2 diabetes mellitus	5.06e-05	0.000621	CcSEcCtD
Labetalol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.04e-05	0.000618	CcSEcCtD
Labetalol—Hypotension—Losartan—type 2 diabetes mellitus	5.04e-05	0.000618	CcSEcCtD
Labetalol—Palpitations—Ramipril—type 2 diabetes mellitus	5e-05	0.000614	CcSEcCtD
Labetalol—Feeling abnormal—Metformin—type 2 diabetes mellitus	5e-05	0.000613	CcSEcCtD
Labetalol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.98e-05	0.00061	CcSEcCtD
Labetalol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.96e-05	0.000609	CcSEcCtD
Labetalol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.96e-05	0.000609	CcSEcCtD
Labetalol—Fatigue—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000605	CcSEcCtD
Labetalol—Salsalate—PTGS2—type 2 diabetes mellitus	4.93e-05	0.0214	CrCbGaD
Labetalol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.91e-05	0.000602	CcSEcCtD
Labetalol—Constipation—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000601	CcSEcCtD
Labetalol—Pain—Irbesartan—type 2 diabetes mellitus	4.9e-05	0.000601	CcSEcCtD
Labetalol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.85e-05	0.000595	CcSEcCtD
Labetalol—Paraesthesia—Losartan—type 2 diabetes mellitus	4.84e-05	0.000593	CcSEcCtD
Labetalol—Urticaria—Metformin—type 2 diabetes mellitus	4.82e-05	0.000591	CcSEcCtD
Labetalol—Dyspnoea—Losartan—type 2 diabetes mellitus	4.8e-05	0.000589	CcSEcCtD
Labetalol—Nausea—Glyburide—type 2 diabetes mellitus	4.8e-05	0.000588	CcSEcCtD
Labetalol—Abdominal pain—Metformin—type 2 diabetes mellitus	4.8e-05	0.000588	CcSEcCtD
Labetalol—Dizziness—Gliclazide—type 2 diabetes mellitus	4.8e-05	0.000588	CcSEcCtD
Labetalol—Somnolence—Losartan—type 2 diabetes mellitus	4.79e-05	0.000588	CcSEcCtD
Labetalol—Asthenia—Valsartan—type 2 diabetes mellitus	4.78e-05	0.000586	CcSEcCtD
Labetalol—Discomfort—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000584	CcSEcCtD
Labetalol—Dyspepsia—Losartan—type 2 diabetes mellitus	4.74e-05	0.000582	CcSEcCtD
Labetalol—Asthenia—Orlistat—type 2 diabetes mellitus	4.72e-05	0.000579	CcSEcCtD
Labetalol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000579	CcSEcCtD
Labetalol—Pruritus—Valsartan—type 2 diabetes mellitus	4.71e-05	0.000578	CcSEcCtD
Labetalol—Propafenone—CYP1A2—type 2 diabetes mellitus	4.7e-05	0.0204	CrCbGaD
Labetalol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.68e-05	0.000574	CcSEcCtD
Labetalol—Confusional state—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000571	CcSEcCtD
Labetalol—Pruritus—Orlistat—type 2 diabetes mellitus	4.66e-05	0.000571	CcSEcCtD
Labetalol—Fatigue—Losartan—type 2 diabetes mellitus	4.65e-05	0.00057	CcSEcCtD
Labetalol—Oedema—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000567	CcSEcCtD
Labetalol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000567	CcSEcCtD
Labetalol—Vomiting—Gliclazide—type 2 diabetes mellitus	4.61e-05	0.000566	CcSEcCtD
Labetalol—Pain—Losartan—type 2 diabetes mellitus	4.61e-05	0.000565	CcSEcCtD
Labetalol—Constipation—Losartan—type 2 diabetes mellitus	4.61e-05	0.000565	CcSEcCtD
Labetalol—Rash—Gliclazide—type 2 diabetes mellitus	4.57e-05	0.000561	CcSEcCtD
Labetalol—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.57e-05	0.00056	CcSEcCtD
Labetalol—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.56e-05	0.000559	CcSEcCtD
Labetalol—Urticaria—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000558	CcSEcCtD
Labetalol—Shock—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000558	CcSEcCtD
Labetalol—Headache—Gliclazide—type 2 diabetes mellitus	4.54e-05	0.000557	CcSEcCtD
Labetalol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000555	CcSEcCtD
Labetalol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.53e-05	0.000555	CcSEcCtD
Labetalol—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.51e-05	0.000553	CcSEcCtD
Labetalol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000548	CcSEcCtD
Labetalol—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.44e-05	0.000545	CcSEcCtD
Labetalol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.41e-05	0.00054	CcSEcCtD
Labetalol—Dizziness—Valsartan—type 2 diabetes mellitus	4.41e-05	0.00054	CcSEcCtD
Labetalol—Dizziness—Orlistat—type 2 diabetes mellitus	4.35e-05	0.000534	CcSEcCtD
Labetalol—Asthenia—Metformin—type 2 diabetes mellitus	4.35e-05	0.000534	CcSEcCtD
Labetalol—Hypotension—Ramipril—type 2 diabetes mellitus	4.32e-05	0.00053	CcSEcCtD
Labetalol—Nausea—Gliclazide—type 2 diabetes mellitus	4.31e-05	0.000528	CcSEcCtD
Labetalol—Pruritus—Metformin—type 2 diabetes mellitus	4.29e-05	0.000527	CcSEcCtD
Labetalol—Urticaria—Losartan—type 2 diabetes mellitus	4.28e-05	0.000525	CcSEcCtD
Labetalol—Abdominal pain—Losartan—type 2 diabetes mellitus	4.26e-05	0.000522	CcSEcCtD
Labetalol—Body temperature increased—Losartan—type 2 diabetes mellitus	4.26e-05	0.000522	CcSEcCtD
Labetalol—Vomiting—Valsartan—type 2 diabetes mellitus	4.24e-05	0.00052	CcSEcCtD
Labetalol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000517	CcSEcCtD
Labetalol—Rash—Valsartan—type 2 diabetes mellitus	4.2e-05	0.000515	CcSEcCtD
Labetalol—Dermatitis—Valsartan—type 2 diabetes mellitus	4.2e-05	0.000515	CcSEcCtD
Labetalol—Vomiting—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000513	CcSEcCtD
Labetalol—Headache—Valsartan—type 2 diabetes mellitus	4.17e-05	0.000512	CcSEcCtD
Labetalol—Diarrhoea—Metformin—type 2 diabetes mellitus	4.15e-05	0.000509	CcSEcCtD
Labetalol—Rash—Orlistat—type 2 diabetes mellitus	4.15e-05	0.000509	CcSEcCtD
Labetalol—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000509	CcSEcCtD
Labetalol—Dermatitis—Orlistat—type 2 diabetes mellitus	4.15e-05	0.000509	CcSEcCtD
Labetalol—Headache—Orlistat—type 2 diabetes mellitus	4.13e-05	0.000506	CcSEcCtD
Labetalol—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000505	CcSEcCtD
Labetalol—Asthenia—Irbesartan—type 2 diabetes mellitus	4.11e-05	0.000504	CcSEcCtD
Labetalol—Somnolence—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000504	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—type 2 diabetes mellitus	4.07e-05	0.0177	CrCbGaD
Labetalol—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.07e-05	0.000499	CcSEcCtD
Labetalol—Pruritus—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000497	CcSEcCtD
Labetalol—Dizziness—Metformin—type 2 diabetes mellitus	4.01e-05	0.000492	CcSEcCtD
Labetalol—Fatigue—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000489	CcSEcCtD
Labetalol—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.97e-05	0.000487	CcSEcCtD
Labetalol—Nausea—Valsartan—type 2 diabetes mellitus	3.96e-05	0.000485	CcSEcCtD
Labetalol—Constipation—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000485	CcSEcCtD
Labetalol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.92e-05	0.000481	CcSEcCtD
Labetalol—Nausea—Orlistat—type 2 diabetes mellitus	3.91e-05	0.00048	CcSEcCtD
Labetalol—Asthenia—Losartan—type 2 diabetes mellitus	3.87e-05	0.000474	CcSEcCtD
Labetalol—Vomiting—Metformin—type 2 diabetes mellitus	3.86e-05	0.000473	CcSEcCtD
Labetalol—Rash—Metformin—type 2 diabetes mellitus	3.83e-05	0.000469	CcSEcCtD
Labetalol—Dermatitis—Metformin—type 2 diabetes mellitus	3.82e-05	0.000469	CcSEcCtD
Labetalol—Pruritus—Losartan—type 2 diabetes mellitus	3.81e-05	0.000468	CcSEcCtD
Labetalol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000467	CcSEcCtD
Labetalol—Headache—Metformin—type 2 diabetes mellitus	3.8e-05	0.000466	CcSEcCtD
Labetalol—Dizziness—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000464	CcSEcCtD
Labetalol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.78e-05	0.000463	CcSEcCtD
Labetalol—Diarrhoea—Losartan—type 2 diabetes mellitus	3.69e-05	0.000452	CcSEcCtD
Labetalol—Urticaria—Ramipril—type 2 diabetes mellitus	3.67e-05	0.00045	CcSEcCtD
Labetalol—Tolterodine—CYP3A4—type 2 diabetes mellitus	3.66e-05	0.0159	CrCbGaD
Labetalol—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000448	CcSEcCtD
Labetalol—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000448	CcSEcCtD
Labetalol—Vomiting—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000447	CcSEcCtD
Labetalol—Fenoprofen—ALB—type 2 diabetes mellitus	3.63e-05	0.0157	CrCbGaD
Labetalol—Rash—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000443	CcSEcCtD
Labetalol—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000442	CcSEcCtD
Labetalol—Nausea—Metformin—type 2 diabetes mellitus	3.6e-05	0.000442	CcSEcCtD
Labetalol—Headache—Irbesartan—type 2 diabetes mellitus	3.59e-05	0.00044	CcSEcCtD
Labetalol—Dizziness—Losartan—type 2 diabetes mellitus	3.56e-05	0.000437	CcSEcCtD
Labetalol—Vomiting—Losartan—type 2 diabetes mellitus	3.43e-05	0.00042	CcSEcCtD
Labetalol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000418	CcSEcCtD
Labetalol—Nausea—Irbesartan—type 2 diabetes mellitus	3.4e-05	0.000417	CcSEcCtD
Labetalol—Rash—Losartan—type 2 diabetes mellitus	3.4e-05	0.000417	CcSEcCtD
Labetalol—Dermatitis—Losartan—type 2 diabetes mellitus	3.4e-05	0.000416	CcSEcCtD
Labetalol—Headache—Losartan—type 2 diabetes mellitus	3.38e-05	0.000414	CcSEcCtD
Labetalol—Asthenia—Ramipril—type 2 diabetes mellitus	3.32e-05	0.000407	CcSEcCtD
Labetalol—Pruritus—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000401	CcSEcCtD
Labetalol—Nausea—Losartan—type 2 diabetes mellitus	3.2e-05	0.000393	CcSEcCtD
Labetalol—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000388	CcSEcCtD
Labetalol—Propafenone—CYP3A4—type 2 diabetes mellitus	3.11e-05	0.0135	CrCbGaD
Labetalol—Dizziness—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000375	CcSEcCtD
Labetalol—Vomiting—Ramipril—type 2 diabetes mellitus	2.94e-05	0.00036	CcSEcCtD
Labetalol—Rash—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000357	CcSEcCtD
Labetalol—Dermatitis—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000357	CcSEcCtD
Labetalol—Headache—Ramipril—type 2 diabetes mellitus	2.9e-05	0.000355	CcSEcCtD
Labetalol—Nausea—Ramipril—type 2 diabetes mellitus	2.74e-05	0.000337	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—type 2 diabetes mellitus	2.66e-05	0.0115	CrCbGaD
Labetalol—Ketoprofen—PTGS2—type 2 diabetes mellitus	2.4e-05	0.0104	CrCbGaD
Labetalol—Flurbiprofen—ALB—type 2 diabetes mellitus	2.37e-05	0.0103	CrCbGaD
Labetalol—Ketoprofen—ALB—type 2 diabetes mellitus	2.14e-05	0.00928	CrCbGaD
Labetalol—ADRB1—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.63e-06	0.000249	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	7.59e-06	0.000248	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INSR—type 2 diabetes mellitus	7.58e-06	0.000248	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	7.51e-06	0.000245	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	7.47e-06	0.000244	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	7.47e-06	0.000244	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	7.47e-06	0.000244	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	7.47e-06	0.000244	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IAPP—type 2 diabetes mellitus	7.46e-06	0.000244	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	7.45e-06	0.000243	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	7.44e-06	0.000243	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INSR—type 2 diabetes mellitus	7.42e-06	0.000242	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	7.41e-06	0.000242	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.4e-06	0.000242	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	7.31e-06	0.000239	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	7.31e-06	0.000239	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	7.29e-06	0.000238	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	7.28e-06	0.000238	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.27e-06	0.000238	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	7.24e-06	0.000237	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	7.16e-06	0.000234	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	7.16e-06	0.000234	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	7.15e-06	0.000233	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—C3—type 2 diabetes mellitus	7.14e-06	0.000233	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—C3—type 2 diabetes mellitus	7.11e-06	0.000232	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	7.09e-06	0.000232	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	6.98e-06	0.000228	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	6.94e-06	0.000227	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.9e-06	0.000225	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	6.89e-06	0.000225	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	6.89e-06	0.000225	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.88e-06	0.000225	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.88e-06	0.000225	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.78e-06	0.000222	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.78e-06	0.000221	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	6.77e-06	0.000221	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.76e-06	0.000221	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	6.75e-06	0.000221	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGT—type 2 diabetes mellitus	6.75e-06	0.000221	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	6.73e-06	0.00022	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	6.73e-06	0.00022	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.7e-06	0.000219	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.67e-06	0.000218	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.67e-06	0.000218	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	6.66e-06	0.000217	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	6.66e-06	0.000217	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	6.66e-06	0.000217	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.64e-06	0.000217	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	6.64e-06	0.000217	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—type 2 diabetes mellitus	6.61e-06	0.000216	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—LEP—type 2 diabetes mellitus	6.61e-06	0.000216	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.55e-06	0.000214	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	6.55e-06	0.000214	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.54e-06	0.000214	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.53e-06	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.53e-06	0.000213	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	6.52e-06	0.000213	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	6.52e-06	0.000213	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.45e-06	0.000211	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	6.41e-06	0.000209	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	6.38e-06	0.000209	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	6.38e-06	0.000209	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	6.31e-06	0.000206	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.27e-06	0.000205	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	6.26e-06	0.000204	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.24e-06	0.000204	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	6.13e-06	0.0002	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	6.07e-06	0.000198	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	6.04e-06	0.000197	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	5.97e-06	0.000195	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.97e-06	0.000195	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	5.94e-06	0.000194	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	5.91e-06	0.000193	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.9e-06	0.000193	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.87e-06	0.000192	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	5.86e-06	0.000191	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.85e-06	0.000191	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	5.84e-06	0.000191	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	5.84e-06	0.000191	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.74e-06	0.000188	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.73e-06	0.000187	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	5.66e-06	0.000185	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	5.66e-06	0.000185	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	5.66e-06	0.000185	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	5.66e-06	0.000185	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—INS—type 2 diabetes mellitus	5.65e-06	0.000185	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.59e-06	0.000182	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.56e-06	0.000182	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.49e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.48e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.47e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.46e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.46e-06	0.000178	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.44e-06	0.000178	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	5.43e-06	0.000177	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.37e-06	0.000175	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.36e-06	0.000175	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.19e-06	0.00017	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.19e-06	0.00017	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.14e-06	0.000168	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	5.08e-06	0.000166	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.08e-06	0.000166	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	5.08e-06	0.000166	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.05e-06	0.000165	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	5.05e-06	0.000165	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	5.03e-06	0.000164	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.03e-06	0.000164	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.98e-06	0.000163	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.96e-06	0.000162	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.96e-06	0.000162	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.96e-06	0.000162	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.96e-06	0.000162	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.94e-06	0.000161	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.92e-06	0.000161	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.91e-06	0.00016	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.89e-06	0.00016	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.87e-06	0.000159	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.83e-06	0.000158	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.8e-06	0.000157	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.78e-06	0.000156	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.72e-06	0.000154	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	4.71e-06	0.000154	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.68e-06	0.000153	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.66e-06	0.000152	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	4.61e-06	0.000151	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	4.61e-06	0.000151	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.59e-06	0.00015	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.58e-06	0.00015	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	4.53e-06	0.000148	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	4.5e-06	0.000147	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	4.5e-06	0.000147	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	4.5e-06	0.000147	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.49e-06	0.000147	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	4.47e-06	0.000146	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.39e-06	0.000144	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.39e-06	0.000143	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.34e-06	0.000142	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.32e-06	0.000141	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.3e-06	0.00014	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.25e-06	0.000139	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.22e-06	0.000138	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	4.22e-06	0.000138	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.21e-06	0.000137	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.18e-06	0.000137	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	4.13e-06	0.000135	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.03e-06	0.000132	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.03e-06	0.000132	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.03e-06	0.000132	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.02e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.01e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.01e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.98e-06	0.00013	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.96e-06	0.000129	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.94e-06	0.000129	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.93e-06	0.000129	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.93e-06	0.000129	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.93e-06	0.000128	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.93e-06	0.000128	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.92e-06	0.000128	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.92e-06	0.000128	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.92e-06	0.000128	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.88e-06	0.000127	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.86e-06	0.000126	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.85e-06	0.000126	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.84e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.84e-06	0.000125	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.84e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.8e-06	0.000124	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.7e-06	0.000121	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.69e-06	0.000121	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.67e-06	0.00012	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.65e-06	0.000119	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.65e-06	0.000119	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.62e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.57e-06	0.000117	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.56e-06	0.000116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.5e-06	0.000114	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.5e-06	0.000114	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.5e-06	0.000114	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.43e-06	0.000112	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	3.35e-06	0.00011	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.3e-06	0.000108	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	3.28e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.28e-06	0.000107	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.24e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.24e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.23e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.23e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.21e-06	0.000105	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.17e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.17e-06	0.000104	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.16e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.08e-06	0.000101	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.01e-06	9.85e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.01e-06	9.85e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.01e-06	9.84e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3e-06	9.8e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.96e-06	9.67e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.94e-06	9.61e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.94e-06	9.61e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.88e-06	9.4e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.88e-06	9.4e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.87e-06	9.39e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.8e-06	9.13e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.77e-06	9.04e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.74e-06	8.96e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.71e-06	8.85e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.69e-06	8.78e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.68e-06	8.75e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.61e-06	8.52e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.57e-06	8.41e-05	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.52e-06	8.23e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.5e-06	8.16e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.48e-06	8.1e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.47e-06	8.07e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.47e-06	8.07e-05	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.47e-06	8.05e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.44e-06	7.98e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.43e-06	7.93e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.42e-06	7.92e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.36e-06	7.71e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.35e-06	7.67e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.33e-06	7.63e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.31e-06	7.54e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.31e-06	7.54e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.3e-06	7.51e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.29e-06	7.48e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.28e-06	7.46e-05	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.28e-06	7.44e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.27e-06	7.43e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.24e-06	7.31e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.18e-06	7.11e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.13e-06	6.95e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.12e-06	6.92e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.07e-06	6.77e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2e-06	6.54e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.97e-06	6.42e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.94e-06	6.35e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.91e-06	6.23e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.9e-06	6.22e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.87e-06	6.09e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.8e-06	5.88e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-06	5.63e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-06	5.63e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.58e-06	5.15e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.47e-06	4.79e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.43e-06	4.68e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.35e-06	4.42e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.32e-06	4.32e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.92e-07	2.59e-05	CbGpPWpGaD
